Areas › Focus, starting, and ADHD › Medication and how it works
A medicine can help some people and still fail to win approval for a condition. Modafinil is the usual example, cleared for a sleep disorder and short of the bar for attention.
Approval turns on trials showing a clear enough average effect for that specific use, and an average can be respectable within a subgroup while missing the threshold. Once a drug falls short, study of it often stops and access narrows behind it. Holding this in mind saves you from two mistakes: reading approval as proof that a drug will work for you, and reading its absence as proof that a drug does nothing.
This explains how treatments work. Never start, stop or change a medication because of something you read here.
Qur’an and Sunnah
'They have no knowledge to base this on: they merely follow guesswork' (Quran 53:28). Confident opinion about what a medicine does, held either way with nothing underneath it, is the thing being described.
وَمَا لَهُم بِهِۦ مِنۡ عِلۡمٍۖ إِن يَتَّبِعُونَ إِلَّا ٱلظَّنَّۖ وَإِنَّ ٱلظَّنَّ لَا يُغۡنِي مِنَ ٱلۡحَقِّ شَيۡـࣰٔ ا
They have no knowledge to base this on: they merely follow guesswork. Guesswork is of no value against the Truth
Qur’an 53:28read it in the library
Translation: M.A.S. Abdel Haleem, The Qur'an, Oxford University Press, 2004.
What the research says
A clinical review covering twenty years of ADHD research sets out what has been established and what has not, including changes to the diagnostic criteria themselves. Read next to the approval process, it is a reminder that the evidence base is uneven rather than finished, and that a drug's regulatory status summarises what has been shown so far. It is not a verdict on the chemistry.
Cortese S, Coghill D. (2018). Twenty years of research on attention-deficit/hyperactivity disorder (ADHD): looking back, looking forward.. Evidence-based mental health doi
Strength of evidence: one line of research. A single study, or a theoretical account.
Why it works
Approval is a statement about averages in trials, not about you.
This one is still a draft. It is waiting on a scholar and a clinician to read it before it is published.
Near this one
Prescribers usually begin below the dose likely to work and build upwards. That means the first weeks can be underwhelming by design, and it is not the moment to decide the whole thing has failed.
For most people who get as far as asking for help with ADHD, medication is the single change that shifts the most. It is not compulsory and plenty live well without it, and it does deserve an honest look rather than a place at the back of the queue.
Non-stimulants are usually tried after the stimulants rather than instead of them, mostly because they are harder to tolerate. That is about order, not about the drug being second rate.